Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Sensitivity and specificity of the consumer open skin allergy test as a method of prediction of contact dermatitis to hair dyes


European Journal of Dermatology. Volume 15, Number 1, 18-25, January-February 2005, Investigative report


Summary  

Author(s) : Maya Krasteva, Martin Cottin, Antonio Cristaudo, Gérard Lainé, Gerhard Nohynek, David Orton, Hervé Toutain, Vincenzo Severino, John Wilkinson , L’Oréal Research and Development, Worldwide Safety Department, 25-29, quai Aulagnier, 92600 Asnières, FranceFax: (+33) 1 47 56 72 68., Department of Dermatology, IFO, Polo Dermatologico San Gallicano, 53, Via E. Chianesi, 00144 Roma, Italy, Department of Dermatology, Hôpital Saint Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France, Department of Dermatology, Amersham Hospital, Whielden street, Amersham, Buckinghamshire HP7 OJD, England.

Summary : To prevent contact dermatitis to oxidative hair colouring products, a consumer test (skin allergy test, SAT) consisting of the open application of the colourant base prior to mixing with the developer is recommended 48 hours before hair colouring. We investigated the sensitivity and specificity of the SAT to detect and prevent contact allergy to oxidative hair colouring products that contained a range of concentrations of para-phenylenediamine (PPD) and corresponded to different shades (light, medium and dark). Test colouring products containing increasing concentrations of PPD (0.1, 0.5, 1.0 or 1.5%) were applied to 34 PPD-positive hair dye-allergic individuals and to 49 non-allergic control subjects. Allergic reactions were elicited in all PPD-positive subjects whereas none occurred in control PPD-negative subjects. For each subject the eliciting concentration of PPD in the SAT was compared with the PPD concentration range of the group of commercial shades reported as causing reactions by the consumer. In all PPD-positive subjects the eliciting concentrations of PPD in the SAT was within or lower than the range of PPD concentrations in the reported eliciting colourant base of commercial products. In conclusion, our results confirm the excellent predictive value of the SAT over the entire range of PPD concentrations used in oxidative hair colouring products and suggest that the test is a suitable tool for the secondary prevention of contact allergic reactions to hair colouring products.

Keywords : PPD:, para-phenylenediamine, PTD:, para-toluenediamine (Toluene-2,5-diamine), SAT:, skin allergy test

Pictures

ARTICLE

Auteur(s) :, Maya Krasteva1,*, Martin Cottin1, Antonio Cristaudo2, Gérard Lainé3, Gerhard Nohynek1, David Orton4, Hervé Toutain1, Vincenzo Severino2, John Wilkinson4

1L’Oréal Research and Development, Worldwide Safety Department, 25-29, quai Aulagnier, 92600 Asnières, FranceFax: (+33) 1 47 56 72 68.
2Department of Dermatology, IFO, Polo Dermatologico San Gallicano, 53, Via E. Chianesi, 00144 Roma, Italy
3Department of Dermatology, Hôpital Saint Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France
4Department of Dermatology, Amersham Hospital, Whielden street, Amersham, Buckinghamshire HP7 OJD, England

accepté le 10 Septembre 2004

In recent decades, the prevalence of contact allergy to the oxidative hair dye ingredient para-phenylenediamine (PPD) has remained stable in the populations of the industrialised world against a background of increasing use of hair dyes. Some authors have even reported a decreasing prevalence [1, 2]. Nevertheless, contact dermatitis to hair colouring products remains an important health concern for consumers and the hair dye industry.In order to protect the consumer against potential adverse reactions to hair colouring products, the hair dye industry recommends that consumers perform a skin allergy test (SAT) prior to hair dyeing [3, 4]. The SAT consists of a 48-hour open application of the neat colourant base of the commercial hair colouring product to the retroauricular area. Labelling precautions advise that consumers should refrain from hair dyeing if the SAT produces itching, reddening or swelling at the application site.In the present study, we investigated the sensitivity and specificity of the SAT to detect contact allergic reactions to hair colouring products. We selected PPD as a model allergen, since a) PPD is a major contact allergen in hair colouring products [5, 6], b) the sensitivity of the test procedure could be best appreciated by using as a model allergen an ingredient which is found at different concentrations in consumer products, thus permitting establishment of a dose-response and c) recruitment of volunteers was facilitated by the presence of PPD in the European standard series and the fact that all patients with suspected contact dermatitis are routinely tested with it [7, 8].A previous multicenter study [4] confirmed the effectiveness of the SAT using a black hair dye with a high (1.8%) content of PPD. All 30 subjects with a history of contact dermatitis to hair colouring products included in the study developed type IV allergic reactions at the test site. However, a suitable preventive test should be able to identify an allergic reaction by testing with an allergen at an equal or lower concentration than that which elicited the adverse reaction under use conditions. In the present study, we investigated the sensitivity and specificity of the SAT to detect contact dermatitis to hair colouring products over a range of concentrations of PPD and typical shades (light, medium and dark) in subjects with confirmed PPD-related contact allergy. We attempted to establish the lowest eliciting concentration of PPD and investigated whether the test concentration was within or below the range of PPD concentrations of the colourant base in the commercial product that had elicited the previous reaction in PPD-positive subjects. Our aim was to confirm the suitability of the SAT for the detection and the secondary prevention of contact sensitivity to hair dyes.

Materials and methods

Three dermatological departments in three different countries (England, Italy and France) participated in the study. The study protocol was approved by the respective Ethics Committees. Informed consent was obtained from all subjects.

Test materials

The PPD concentrations of more than two thousand PPD-containing commercial products marketed worldwide were reviewed and 3 groups of shades were defined based on the results: a) light shades (typical range: 0.02-0.39% PPD in colourant base before mixing with the developer), b) medium shades (0.14-1.34% PPD) and c) dark shades (0.74-2.0% PPD). Accordingly, three experimental test product prototypes from these groups were formulated: Product A (containing 0.1% PPD, representative of light shades), Product B (containing 0.5% PPD, representative of medium shades) and Product D (containing 1.5% PPD, representative of dark shades). An additional experimental test product, Product C, containing 1.0% PPD, corresponded to the test material in the European standard series.

The 4 experimental test colourant formulations corresponded to modern hair dyes and contained typical ingredients, such as resorcinol, meta-Aminophenol and 2,4-Diaminophenoxyethanol, ranging from 0.1% (product A) to 1.64% (product D). The matrices consisted of water, surfactants (max. 30%), conditioning agents (max. 5%), alkalising agents (max. 3%), antioxidants and stabilisers (max. 1%) and perfume (max. 0.5%).

The control test materials coded Y (control product for test products A and B) or Z (control for C and D) corresponded to the respective test substances, but contained neither PPD, nor any other colourant molecule.

Subjects

PPD-positive subjects

The experimental group comprised 34 subjects, 1 male and 33 females, aged 23-68 years (mean: 48 ± 11 years). Four subjects belonged to the skin phototypes V and VI (two were of Asian and two of African origin), while the remaining 30 were Caucasians.

Thirty seven subjects with positive patch test reactions to PPD (+ to +++) during routine investigation in the last five years were initially included in the experimental group. All had self-declared clinical manifestations compatible with non-occupational contact dermatitis to oxidative hair colouring products. Exclusion criteria were current acute or widespread eczema at any site, any eczema at the test sites within the last 3 months and participation in diagnostic patch testing during 6 weeks prior to the study. One subject was excluded from the study because the clinical diagnosis and the eliciting agent could not be confirmed, whereas another subject dropped out from the study after the first product application. An additional subject was excluded from the statistical analysis because she was patch test-negative to PPD when re-tested at the end of the study (see results). Therefore the statistical analysis was carried out on 34 subjects.

Subjects were requested to report the shade and brand of commercial hair colouring products that had elicited previous contact dermatitis reactions. This was achieved with the help of colour charts and presentation of packages of commercial hair colouring products. Nine subjects reported reactions to light shade, 15 to medium shade and 10 to dark shade oxidative hair dyes. Seventeen study subjects reported reactions to professional, and 17 to home-use products. In 19 subjects, the reported eliciting products contained PPD, whereas in 4 they contained para-toluenediamine (PTD). In the remaining 11 subjects the eliciting commercial product could not be identified. Clinical manifestations following product use prior to the inclusion in the study are shown in table 1( Table 1 ). Medical treatment was confirmed in 20 subjects: 8/20 were treated with antihistamines, 15 with topical corticosteroids, 3 with systemic corticosteroids, whereas 3 had no medical treatment.

The results from diagnostic patch testing of the study subjects are shown in table 2( Table 2 ).
Table 1 Clinical manifestations in PPD patch test-positive subjects (declarative data by study subjects, verified by the investigators)

Eczematous contact dermatitis of the scalp ± neighbouring skin (forehead, ears, etc)

Contact dermatitis on remote areas (arms, forearms, body)

Oedema of eyelids ± forehead or neck

Whole facial oedema

33/34

4/34

10/34

4/34


Table 2 Positive results from diagnostic patch testing prior to the inclusion of the subjects in the study. All subjects were tested with the European standard series and some were tested with additional series

PPD

Other contact allergens

(Toluene-2,5-diamine) (PTD) : 14/22

p-Aminophenol : 3/6

p-Aminoazobenzene : 5/6

+ : 2/34

Disperse orange 3 : 16/20

++ : 24/34

Disperse yellow 3 : 2/19

+++ : 8/34

o-Nitro-p-phenylenediamine (ONPPD) : 1/16

N-Isopropyl-N-phenyl-4-phenylenediamine (IPPD) : 2/34

Nickel : 10/34

Fragrance mix : 2/34

PPD-negative control subjects

Fifty control subjects with a negative patch test to PPD and related allergens and no history of adverse reactions to hair dyes entered the study. Four control groups of 12 to 13 control subjects were sex- and age-matched to the groups of PPD-positive subjects that had reacted respectively to products A, B, C and D. One subject was found to be positive to an ingredient of the test products and was excluded from the control group (see results); therefore the statistical analysis was carried out on 49 control subjects.

Study design

PPD-positive subjects

PPD-positive subjects were tested consecutively with experimental products containing rising concentrations of PPD (products A through D); the corresponding control product was applied simultaneously. Subjects were allowed a rest period of 3 to 6 weeks between two consecutive applications of test products. When test products produced definite allergic reactions (at least erythema with papules or homogeneous infiltration/œdema), the subject was classified as SAT-positive and testing with products containing higher concentrations of PPD was discontinued for ethical reasons.

PPD-negative control subjects

PPD-negative subjects were tested with one experimental product only and with the corresponding control product. The experimental product was the one that had elicited positive reactions in the group of experimental subjects to which the control group was sex- and age-matched.

The experimental product and the corresponding control product were applied after placing circular adhesive devices (3M) behind each ear. 0.1 ml of products was applied to the centre of the device by means of a micropipette (Multipette 4780, Eppendorf) and combitips (Eppendorf). The products were spread over the skin surface enclosed by the adhesive device (1.75 cm2). The actual volume of the test material applied was approximately 0.08 ml. Given that discolouration at the test site revealed the presence of colourants in the experimental product, the applications of experimental and control products were not blinded.

Adhesive devices were removed 1 hour after application. The test products were left for 48 hours without washing. Reactions were recorded on Day 0 (1 hour post-application), Day 2 (48 ± 2 hours post-application) and Day 4 (96 ± 2 hours post-application).

In the absence of a universally accepted method for grading results of open tests, we used a scoring method based on the proposal of Johansen et al. [9]. The method included: a) a global evaluation of the severity of the reaction, corresponding to the overall clinical impression of the investigator using a five-point grading scale for the allergic reactions. To enable statistical calculations, values were attributed as follows: negative = 0; doubtful = 1; weakly positive = 2; moderately positive = 3 and strongly positive = 4; b) an objective evaluation using a set of objective parameters including: i) involved area of application (scored 0-5), ii) erythema: pattern of involvement (0-2) and strength (1-3), iii) papules, infiltration and/or oedema (0-4), iv) vesicles and/or erosions (0-4) and v) sensory manifestations reported by the patients (0-1). The maximal total score for each reading time point was 19. On Day 2 after treatment, the subjects were requested to report the earliest manifestations they had noted and the time of onset.

Follow-up

PPD-positive subjects with no reaction or doubtful reactions to product D underwent a diagnostic patch test to PPD at least 3 weeks after the SAT. At least 3 weeks after any positive reaction to the SAT to either the test or control products in control subjects or to the control product in PPD-positive subjects, a diagnostic patch test including all the ingredients of the incriminated formulation was performed. The ingredients were tested at their usual diagnostic concentrations or at typical product concentrations. The diagnostic patch tests were graded according to the ICDRG grading scale [8, 10].

A confirming challenge test (use test) was carried out in any PPD-positive subject who reacted to test product D containing a PPD concentration above the concentration range of the shade group to which they had reported previous reactions. For this purpose product B, representative of the group of shades to which the eliciting hair colouring product belonged, was mixed with a developer (6% hydrogen peroxide) and applied to a large strand of hair. The corresponding control product Y was applied on the contralateral side under the same conditions. Each contact area on the scalp had a surface area of 7 cm2. The hair colouring products were rinsed off after 30 minutes and skin reactions were scored 20 minutes, 1, 3 and 6 days later. The use test reactions were graded using the same method as the skin sensitivity test.

Statistical analysis

Student, Levene and Mantel-Haenzel tests were used to assure that the control subjects were sex- and age-matched to the groups of PPD-positive subjects. Probability values of p < 0.05 were considered to be significant.

Mantel-Haenzel’s tests were used to compare the evaluation of the reactions scored as “overall clinical impression” to each of the test products and to the corresponding control products in PPD-positive and PPD negative subjects at all reading times. To assure a probability value of p < 0.05 for the totality of the comparisons, p < 0.008 was considered to be significant for each of the paired comparisons.

Analysis of variances followed by Tukey’s tests was used to compare the objective numerical scores of the reactions between PPD-positive and PPD-negative subjects, and between test products and corresponding control products. Probability values of p < 0.05 were considered to be significant.

Kendall’s Tau-b was used to evaluate the correlation between the overall clinical evaluation and objective numerical scores of the reactions. Correlation was considered to be significant when the absolute value of Tau-b was greater than 0.6.

Results

Reactions to Product A (0.1% PPD) and/or Control Y

Twenty seven out of 34 PPD patch test-positive subjects reacted to the SAT with product A (light shade prototype) with a definite allergic reaction. Reactions included at least erythema with either papules or homogeneous infiltration on Day 2. In 22/27 subjects, vesicles were present. Reactions were evaluated as weakly positive (2/27), moderately positive (12/27) or strongly positive (13/27).

A PPD-negative control subject reacted strongly positive (erythema, infiltration and vesicles) to test product A and to the corresponding control product Y. The subject was subsequently patch tested with the ingredients of the two formulations and was found positive to sodium metabisulfite present in both formulations. The subject was therefore excluded from the control group. All remaining 11 PPD-negative subjects showed negative reactions to products A and Y.

The time-course of the reactions to products A and Y in the 27 PPD-positive subjects who reacted to product A and in the 11 PPD-negative controls is shown on ( figure 1 ). The most severe reactions to product A in PPD-positive subjects were observed on Day 2 and continued to be present, albeit with lower severity, on Day 4.

No reactions were graded as positive in PPD-positive or PPD-negative subjects to the control product Y, or in PPD-negative control subjects to the test product A, although several test sites showed low grade erythema, which remained unnoticed by the subjects.

The severity of the reactions to product A in PPD-positive subjects was statistically higher than the severity of the reactions to the control product in PPD-positive subjects and higher than the severity of the reactions to the experimental and to the control products in PPD-negative subjects, both on Day 2 and Day 4 (p < 0.001). There was no statistically significant difference on Day 0. The same conclusions were obtained when analysing the “overall clinical impression” or the objective numerical scores of the reactions.

The remaining 7 PPD-positive subjects that failed to react to test product A were subsequently tested with products B and Y.

Reactions to Products B (0.5% PPD), C (1% PPD) or D (1.5%PPD) and/or corresponding Controls Y or Z

Three PPD-positive subjects responded on Day 2 to product B with a definite allergic reaction (erythema, infiltration and vesicles) and completed the study.

The 4 remaining PPD-positive test subjects were treated with product C and the corresponding control product Z. Three subjects developed on Day 2 definite allergic reactions to product C.

The last PPD-positive subject that had failed to respond with an allergic reaction to products A, B or C showed a clear allergic reaction to product D (erythema, infiltration and vesicles) on Day 2.

One subject with an initial positive patch test to PPD included in the study was negative to all test products at all readings. The subject was patch tested with PPD 1% in petrolatum on two different occasions two months apart and was found repeatedly negative. Therefore, the subject was classified as no longer being sensitised to PPD and was excluded from the statistical evaluation.

Three groups of sex and age-matched PPD-negative control subjects were tested respectively with products B (n = 13), C (n = 12) or D (n = 13) and corresponding control products. All reactions in the control subjects were graded negative.

Given the low number of PPD-positive subjects reacting to product B (n = 3), C (n = 3) and D (n = 1), no statistical comparison between these groups and corresponding control groups was performed. However, in these groups the reactions to the test products and the corresponding control products both in PPD-positive and in PPD-negative subjects followed the same pattern as the reactions of observed to products A and Y, i.e. PPD-positive subjects developed definite allergic reactions on Days 2 or 4 to the experimental products containing PPD, whereas PPD-negative subjects did not (table 3( Table 3 )).

A statistical analysis carried out in all 34 PPD-positive subjects and 49 PPD-negative controls showed that, on Days 2 and 4, PPD-positive subjects had a statistically significant greater severity of reactions to PPD-containing products when compared with that to the control products (p < 0.001). On Day 0, there were no statistically significant differences between the severities of the reactions in PPD-positive or negative subjects to the experimental or control products. The highest values of objective scores and clinical gradings of the reactions to PPD-containing experimental products in PPD-positive subjects were observed on Day 2. The results obtained by the two methods of evaluation on Day 2 in all the subjects were significantly correlated (Kendal’s tau b = 0.78).

Table 4( Table 4 ) shows the number of PPD-positive subjects that developed a definite allergic reaction to one of the test products on Day 2. Keeping in mind that PPD-positive subjects were progressively withdrawn from the study as soon as they developed an allergic reaction and assuming that the application of a product containing a higher concentration of allergen would be expected to elicit the same or a stronger allergic reaction, cumulative percentages were calculated for products B, C and D. Accordingly, 88% of the subjects would have reacted to Product B (0.5% PPD), 97% to product C (1% PPD) and 100% to product D (1.5% PPD). Overall, 15/34 (44%) subjects showed strongly positive reactions, 13/34 (38%) had moderately positive reactions and 6/34 (18%) had weakly positive reactions to PPD-containing test products. Twenty seven from 34 reactions (79%) were vesicular.

All PPD-positive subjects reported that they had noticed a reaction to the SAT with the PPD-containing product. Pruritus, appearing 5-28 hours post-application (mean time of onset 15.4 hours) was the first symptom reported by 33/34 subjects.

Interestingly, the 4 subjects that had designated PTD-containing hair dyes as eliciting reacted positively to PPD-containing test products. Two of them reacted to product A (0.1% PPD), the remaining 2 to product C (1% PPD). Subjects with skin phototypes V and VI displayed the same type of reactivity as the lighter phototypes: definite allergic reactions were recorded on Day 2 to product A in 3/4 and to product B in 1/4 subjects.
Table 3 Mean severity of reactions (overall clinical impression) to test products A (0.1% PPD), B (0.5% PPD), C (1.0% PPD) and D (1.5% PPD) and to the corresponding control products (Y and Z) in PPD-positive and PPD-negative subjects. 0 = negative reaction; 1 = doubtful; 2 = weakly positive; 3 = moderately positive; 4 = strongly positive

Subject group

Test product

Content PPD (%)

Day 0

Day 2

Day 4

PPD-positive

A

0.1

0.07

3.41

2.85

PPD-positive

B

0.5

0.3

3.67

3

PPD-positive

C

1.0

0

2

1.3

PPD-positive

D

1.5

0

2

2

PPD-positive

Y tested with A

0.0 (Control)

0.04

0

0

PPD-positive

Y tested with B

0.0 (Control)

0.3

0

0

PPD-positive

Z tested with C

0.0 (Control)

0

0

0

PPD-positive

Z tested with D

0.0 (Control)

0

0

0

PPD-negative

A

0.1

0

0

0

PPD-negative

B

0.5

0

0

0

PPD-negative

C

1.0

0

0

0

PPD-negative

D

1.5

0

0

0

PPD-negative

Y tested with A

0.0 (Control)

0

0

0

PPD-negative

Y tested with B

0.0 (Control)

0

0.1

0

PPD-negative

Z tested with C

0.0 (Control)

0

0

0

PPD-negative

Z tested with D

0.0 (Control)

0

0

0


Table 4 Number of PPD-positive subjects developing positive reactions to the test products on Day 2 after application
  • Product A
  • (0.1% PPD)


  • Product B
  • (0.5% PPD)


  • Product C
  • (1% PPD)


  • Product D
  • (1.5% PPD)


Number of subjects reacting

27/34

3/34

3/34

1/34

% of subjects reacting

79.4

8.8

8.8

2.9

Cumulative percentage of subjects reacting to the respective test product

79.4

88.2

97

100

Comparison of the eliciting PPD concentrations in the study (experimental data) with the PPD concentrations present in the colourant base of the eliciting commercial product (declarative data)

In order to evaluate the sensitivity of the SAT and its predictive value for each individual test subject, the eliciting concentrations of PPD under the study conditions were compared with the PPD concentrations in the colourant base of the reported, eliciting commercial products, i.e. the PPD concentration range in the group of hair dye shades claimed as eliciting by the consumer. ( Figure 2 ) shows the relation between experimental and declarative data.

With a single exception, the SAT was predictive of contact dermatitis to the corresponding shade of hair dyes reported as eliciting by the subject. Indeed, most subjects reacted to test products containing PPD concentrations lower than the concentration ranges of the respective commercial group of shades (20/34).

However, a single subject reported a history of contact dermatitis to medium shades, but reacted only to product D (1.5% PPD, dark shade prototype). In this subject, the SAT seemed to be less predictive of contact dermatitis produced by the respective commercial hair dye. In order to verify the presence of allergy to medium shades in this subject, we carried out a use test with product B (medium shade prototype) and the control product Y. Neither product elicited an allergic reaction on the scalp (readings on Days 0, 1, 3 and 6). It was therefore concluded that there was no evidence of contact dermatitis to medium shades at the time of the study.

Discussion

We investigated the sensitivity and specificity of the SAT in 34 PPD-positive subjects with a history of contact dermatitis to oxidative hair dyes using hair colouring products containing 0.1, 0.5, 1.0 or 1.5% PPD. When subjected to the SAT, all subjects developed definite type IV allergic reactions (erythema and papules or homogeneous infiltration) to the PPD-containing test products within 2 days. Although the experimental products were open tested, the nature and severity of the reactions satisfied the criteria of a moderate and strong reaction by the ICDRG grading scale for evaluating occlusive patch tests in 27/34 subjects (presence of vesicles, sometimes coalescing into bullae). Most importantly, the findings were not only rated as positive by classical dermatological criteria, but were also noticed and reported by the study subjects. All PPD-positive subjects felt the development of a reaction, pruritus being the first warning symptom. As the most severe reactions occurred on Day 2, the recommendation to perform the SAT 2 days prior to hair dyeing is consistent with the time course of the allergic reactions observed in our study.

Given that 4 subjects with skin phototypes V and VI displayed a similar reactivity as the subjects with lighter skin, the SAT appears to be able to predict contact dermatitis to hair colouring products in individuals with darker skin types.

In the majority of cases (27/34), open application of a test product containing as little as 0.1% PPD produced manifestations that included all typical features of allergic contact dermatitis. Experimental studies have shown that in a sensitized person the exposure to a higher allergen dose on a constant surface area results in reactions with higher severity [11]. Taking into account ethical considerations, human elicitation studies refrain from application of higher concentrations when a definite allergic reaction is observed [12-14]. Given that a more severe reaction may be expected to a product containing PPD above the first eliciting concentration, we refrained from applying higher concentrations whenever a subject developed a clear-cut contact allergic reaction to the test products. Therefore, when 27 subjects completed the study after reacting to product A (0.1% PPD), only seven subjects remained to be tested with products containing higher PPD concentrations. Overall, the cumulative response rates of subjects reacting to products containing 0.1, 0.5, 1.0 or 1.5% PPD were 27/34, 30/34, 33/34 or 34/34, corresponding to 79, 88, 97 or 100% of the study subjects, respectively.

These results confirm the data of our previous study using a 1.8% PPD-containing dark hair dye. In that study, the SAT yielded a good predictive value for identification of hair dye contact dermatitis. The results of the present study demonstrate that a SAT with lower concentrations of PPD may also be predictive of contact dermatitis to hair dyes.

Some previous studies reported that open application of PPD may elicit contact dermatitis [15-17]. A study in which two PPD-containing hair dyes were tested open in a limited number of subjects found the same order of responsiveness as our present study: 3/8 PPD-positive subjects were reported to react to the hair colouring product containing as little as 0.1% PPD whereas 8/8 reacted to the hair colouring product containing 1% PPD [16].

Although the elicitation dose-response to PPD has been studied under occlusive patch tests and in open application [16, 18, 19], none of these studies compared the eliciting experimental concentrations with those of commercial products under their conditions of use. In contrast, our study also investigated PPD concentrations in the eliciting commercial products (declarative data). Since the study subjects were able to report the shades and, in a majority of cases, even the brands of previously used commercial products, we were able to determine the nature of the principal colourant base (PPD or PTD) and their concentration range in the originally eliciting commercial product. A drawback of this approach, which relies on the recollection of events that may have occurred several years previously, is the possibility of changes in the threshold of elicitation. Indeed, one subject from the PPD-positive group underwent testing with all the experimental products without developing an allergic reaction and was found negative in 2 subsequent patch tests with 1% PPD under a Finn chamber. This subject had either lost her contact sensitivity to PPD or her level of sensitivity may now have been below the threshold of testing. Another subject reacted only to product D (dark shades prototype) while reporting a history of contact dermatitis to medium shade hair dyes. A use test confirmed that at the time of the study there was no evidence of contact dermatitis to medium shades. However, this finding is not surprising, since considerable variation of the elicitation thresholds under patch test [20-23] or use conditions [24-26] is a well known phenomenon which may ultimately progress to loss of contact sensitisation or a state of clinical tolerance [27-29].

Our results demonstrate that the eliciting concentration of PPD when applied under conditions of the SAT is equal to or lower than the PPD concentration in the colourant base of the respective commercial product responsible for elicitation of previous reactions. This finding confirms the sensitivity and specificity of the SAT over the entire range of PPD concentrations used in hair colouring products.

Overall, our previous and present studies confirm that the SAT application of the neat colourant reliably detects contact dermatitis to PPD-containing hair colouring products. The excellent predictive value of the SAT implies that mixing with the developer is not required for the efficiency of the skin sensitivity test. In addition, our data suggests that the colourant base alone and not products of the oxidative reaction are responsible for the allergic reaction.

Our results also suggest that the SAT is highly specific: although some control subjects showed low grade erythema, not a single reaction to the experimental and control products was scored as positive in PPD-negative subjects, or to the control products in PPD-positive subjects.

Finally, it is noteworthy that a control product and its corresponding test product containing sodium metabisulfite produced strongly positive reactions in a sodium metabisulfite-positive subject of the control group. This accidental finding confirms the predictive value of the SAT and suggests that the test may be efficient not only for detection of hair dye contact dermatitis related to PPD, but also for detection of allergies related to other ingredients.

Overall, our data demonstrate an excellent sensitivity and specificity of the SAT over the complete range of PPD concentrations used in hair colouring products. Our results indicate that the SAT using the neat colourant base is sufficient to detect and predict contact sensitivity to hair colouring products and is therefore an important tool for the secondary prevention of hair dye contact dermatitis.

Acknowledgements

We thank Anne-Lise Garcel from L’Oréal Research and Development, Asnières, France for the statistical evaluation of data.

References

1 Maouad M, Fleischer AB, Sherertz EF, et al. Significance-prevalence index number: a re-interpretation and enhancement of data from the North American Contact Dermatitis Group. J Am Acad Dermatol 1999; 41: 573-6.

2 Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. Am J Cont Dermatitis 2003; 14: 59-62.

3 Calnan C. Adverse reactions to hair products. In: Zwiak C, ed. The science of hair care. New York and Basel: Marcel Dekker Inc, 1986: 409-23.

4 Krasteva MK, Cristaudo A, Hall B, et al. Contact sensitivity to hair dyes can be detected by the consumer open test. Eur J Dermatol 2002; 12: 322-6.

5 Frosch PJ, Burrows D, Camarasa JG, et al. Allergic reactions to a hairdressers’ series: results from 9 European centres. Contact Dermatitis 1993; 28: 180-3.

6 Rietschel RL, Fowler JF. Allergy to preservatives and vehicles in cosmetics and toiletry. In: Rietschel RL, Fowler JF, eds. Fisher’s contact dermatitis. 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2001: 211-59.

7 Krasteva M, Kehren J, Sayag M, et al. Contact dermatitis. II. Clinical aspects and diagnosis. Eur J Dermatol 1999; 9: 144-59.

8 Devos SA, Van Der Valk PG. Epicutaneous patch testing. Eur J Dermatol 2002; 12: 506-13.

9 Johansen JD, Bruze M, Andersen KE, et al. The repeated open application test: suggestions for a scale evaluation. Contact Dermatitis 1997; 39: 95-6.

10 Fregert S. Manual of contact dermatitis. 2nd edition. Copenhagen: Munksgaard, 1981.

11 Friedmann PS, Moss C, Shuster S, et al. Quantitation of sensitization and responsiveness to dinitrochlorobenzene in normal subjects. Br J Dermatol 1983; 109(Suppl 25): 86-8.

12 Basketter D, Horev L, Slodovnik D, et al. Investigation of the threshold for allergic reactivity to chromium. Contact Dermatitis 2001; 44: 70-4.

13 Bruze M, Johansen JD, Andersen KE, et al. Deodorants: An experimental provocation study with cinnamic aldehyde. J Am Acad Dermatol 2003; 48: 194-200.

14 Svedman C, Bruze M, Johansen JD, et al. Deodorants: An experimental provocation study with hydroxycitronellal. Contact Dermatitis 2003; 48: 217-23.

15 Epstein WL, Taylor MK. Experimental sensitization to paraphenylenediamine and paratoluenediamine in man. Acta Dermatovenereol 1979; 59: 55-7.

16 Ishihara M, Nogami T, Itoh M, et al. Basic studies on contact dermatitis due to hair colourings and cold permanent wave solutions. Japanese Cosmetic Journal 1983; 7: 272-82.

17 Reiss F, Gahwiler M, Lustig B. Sensitivity to hair dyes. J Allergy 1957; 28: 134-41.

18 Hextall JM, Alagaratnam NJ, Glendinning AK, et al. Dose-time relationships for the elicitation of contact allergy to para-phenylenediamine. Contact Dermatitis 2002; 47: 96-9.

19 McFadden JP, Wakelin SH, Holloway DB, et al. The effect of duration on the elicitation of para-phenylenediamine contact allergy. Contact Dermatitis 1998; 39: 79-81.

20 Hindsen M, Bruze M, Christensen OB. Individual variation in nickel patch test reactivity. Am J Contact Dermatitis 1999; 10: 62-7.

21 Ayala F, Balato N, Lembo G. Statistical evaluation of the persistence of acquired hypersensitivity by standardized patch tests. Contact Dermatitis 1996; 34: 354-8.

22 Valsecchi R, Rossi A, Bigardi A, et al. The loss of contact sensitization in man. Contact Dermatitis 1991; 24: 183-6.

23 Nielsen NH, Linneberg A, Menné T, et al. Persistence of contact allergy among Danish adults: an 8-year follow-up study. Contact Dermatitis 2001; 45: 350-3.

24 Epstein WL. Poison oak and poison ivy dermatitis. In: Adams RM, ed. Occupational skin disease. Philadelphia: WB Saunders Company, 1990: 536-42; 2nd edition.

25 Seo KI, Eun HC. Loss of contact sensitization evaluated by laser doppler blood flowmetry and transepidermal water loss measurement. Contact Dermatitis 1996; 34: 233-6.

26 Mastrolonardo M, Lopalco PL, Diaferio A. Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity. Contact Dermatitis 2002; 47: 214-214.

27 Chan YC, Ng SK, Goh CL. Positive patch test reactions to para-phenylenediamine, their clinical relevance and the concept of clinical tolerance. Contact Dermatitis 2001; 45: 217-20.

28 Krasteva M, Kehren J, Ducluzeau MT, et al. Contact dermatitis. I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999; 9: 65-77.

29 Saint-Mézard P, Bérard F, Dubois B, et al. The role of CD4+ and CD8+ T cells in contact sensitivity and allergic contact dermatitis. Eur J Dermatol 2004; 14: 131-8.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]